HRMY
Harmony Biosciences Holdings, Inc.
Key Financials
Revenue
$868.5M
↑ 21.5%
Gross Profit
$670.1M
↑ 20.1%
EPS (Diluted)
$2.71
↑ 8.0%
Total Assets
$1.3B
↑ 27.3%
Operating Income
$208.5M
↑ 9.2%
Net Income
$158.7M
↑ 9.1%
Cash & Equivalents
$752.5M
↑ 66.1%
Shareholders' Equity
$870.2M
↑ 32.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HRMY |
| Company Name | Harmony Biosciences Holdings, Inc. |
| CIK | 1802665 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (484) 539-9800 |